Hepatitis Monthly

Published by: Kowsar

A Population Based Study on Hepatitis B Virus in Northern Iran, Amol

Hossein Keyvani 1 , Masoudreza Sohrabi 2 , Farhad Zamani 2 , * , Hossein Poustchi 3 , Hossein Ashrafi 4 , Fatemeh Saeedian 2 , Mansooreh Mooadi 2 , Nima Motamed 2 , Hossein Ajdarkosh 2 , Mahmoodreza Khonsari 2 , Gholamreza Hemmasi 2 , Mitra Ameli 2 , Ali Kabir 5 and Mahmoud Khodadost 2
Authors Information
1 Department of Virology, Iran University of Medical Sciences, Tehran, IR Iran
2 Gastrointestinal and Liver Diseases Research Center (GILDRC), Iran University of Medical Sciences, Tehran, IR Iran
3 Liver and Pancreatobiliary Disease Research Center, Digestive Disease Research institute (DDRI), Tehran University of Medical Sciences, Tehran, IR Iran
4 Department of Pathology, Kingston University, London, UK
5 Department of Epidemiology, School of Publich Health, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: August 01, 2014, 14 (8); e20540
  • Published Online: August 17, 2014
  • Article Type: Research Article
  • Received: May 22, 2014
  • Revised: June 18, 2014
  • Accepted: July 18, 2014
  • DOI: 10.5812/hepatmon.20540

To Cite: Keyvani H, Sohrabi M, Zamani F, Poustchi H, Ashrafi H, et al. A Population Based Study on Hepatitis B Virus in Northern Iran, Amol, Hepat Mon. 2014 ; 14(8):e20540. doi: 10.5812/hepatmon.20540.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Chen DS. Toward elimination and eradication of hepatitis B. J Gastroenterol Hepatol. 2010; 25(1): 19-25[DOI][PubMed]
  • 2. Kwon SY, Lee CH. Epidemiology and prevention of hepatitis B virus infection. Korean J Hepatol. 2011; 17(2): 87-95[DOI][PubMed]
  • 3. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): 2212-9[DOI][PubMed]
  • 4. Riaz M, Idrees M, Kanwal H, Kabir F. An overview of triple infection with hepatitis B, C and D viruses. Virol J. 2011; 8: 368[DOI][PubMed]
  • 5. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2005; 34 Suppl 1-3[PubMed]
  • 6. Specialist Panel on Chronic Hepatitis BitME. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat. 2012; 19(1): 9-22[DOI][PubMed]
  • 7. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000; 18 Suppl 1-2[PubMed]
  • 8. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005; 11(1-2): 62-7[PubMed]
  • 9. Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, et al. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. 2012; 3(11): 770-5[PubMed]
  • 10. Pourhoseingholi MA, Fazeli Z, Zali MR, Alavian SM. Burden of hepatocellular carcinoma in Iran; Bayesian projection and trend analysis. Asian Pac J Cancer Prev. 2010; 11(4): 859-62[PubMed]
  • 11. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 12. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008; 8(4)
  • 13. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009; 49(10): 2214-20[DOI][PubMed]
  • 14. Alavian SM, Fallahian F, Lankarani KB. Implementing strategies for hepatitis B vaccination. Saudi J Kidney Dis Transpl. 2010; 21(1): 10-22[PubMed]
  • 15. Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland W, et al. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran. AIDS Care. 2014; 26(9): 1122-6[DOI][PubMed]
  • 16. Attaran MS, Sharifi Z, Hosseini SM, Samei S, Ataee Z. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran. APMIS. 2014; 122(3): 243-7[DOI][PubMed]
  • 17. Shakeri MT, Foghanian B, Nomani H, Ghayour-Mobarhan M, Nabavinia MS, Rostami S, et al. The prevalence of hepatitis B virus infection in mashhad, iran: a population-based study. Iran Red Crescent Med J. 2013; 15(3): 245-8[DOI][PubMed]
  • 18. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
  • 19. Moghaddam ES, Khosravi S, Ghorbani GA, Alavian SM. Hepatitis B core antibody in blood donor in Sistan-Balutuestan province of Iran. Indian J Med Sci. 2010; 64(9): 391-5[DOI][PubMed]
  • 20. Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010; 4(10): 658-61[PubMed]
  • 21. Salehi M, Alavian SM, Tabatabaei SV, Izadi S, Sanei Moghaddam E, Amini Kafi-Abad S, et al. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5): 283-8[PubMed]
  • 22. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res. 2006; 123(1): 37-42[PubMed]
  • 23. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011; 11(5): 346-50[PubMed]
  • 24. Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, et al. Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon. 2012; 12(2): 112-7
  • 25. Ansari-Moghaddam A, Ostovaneh MR, Sharifi Mood B, Sanei-Moghaddam E, Modabbernia A, Poustchi H. Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study. Hepat Mon. 2012; 12(9)[DOI][PubMed]
  • 26. Hajian E, Hashemi SJ, Masjedizadeh AR. Seroepidemiology of Hepatitis B virus infection in Khuzestan province ,southwest of Iran Hepat Mon 2009; 9(1): 34-8
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments